+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

MK-130, a new drug for the treatment of muscular hypertonia. Preliminary trial in 10 patients with spasticity of spinal origin



MK-130, a new drug for the treatment of muscular hypertonia. Preliminary trial in 10 patients with spasticity of spinal origin



L'Union Medicale du Canada 100(10): 1947-1951




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 043570216

Download citation: RISBibTeXText

PMID: 5142212


Related references

Pathophysiology of impairment in patients with spasticity and use of stretch as a treatment of spastic hypertonia. Physical Medicine and Rehabilitation Clinics of North America 12(4): 747, 2001

4261 CB tetrazepam trial in a series of 42 patients with hypertonia of different origin. Marseille Medical 106(12): 1081-1085, 1969

Intrathecal baclofen for intractable spasticity of spinal origin preliminary results of a multicenter study. Stereotactic & Functional Neurosurgery 54-55: 217-218, 1990

Spinal Cord Stimulation (SCS) Versus Intrathecal Drug Infusion (IDI) for the Treatment of Spinal Spasticity. Neuromodulation: Technology at the Neural Interface 6(3): 200-201, 2003

Effect of whole-body vibration on quadriceps spasticity in individuals with spastic hypertonia due to spinal cord injury. Restorative Neurology and Neuroscience 27(6): 621-631, 2009

Intrathecal baclofen for spasticity management: a comparative analysis of spasticity of spinal vs cortical origin. Journal of Spinal Cord Medicine 33(1): 16-21, 2010

Treatment of rigidity and of muscular spasticity in infantile paralysis by hypo thermia of the spinal cord. Neurochirurgie: 50, 1982

Pharmacological treatment of muscular hypertonia. II. Action of various pharmacological combinations on hypertonia in decerebrate animals. Bollettino Della Societa Italiana di Biologia Sperimentale 31(5): 469-471, 1955

Pharmacological treatment of muscular hypertonia. III. Actions of various pharmacological combinations on hypertonia in decerebrate animals. Bollettino Della Societa Italiana di Biologia Sperimentale 31(5): 472-474, 1955

Extracorporeal Shock Wave Stimulation as Alternative Treatment Modality for Wrist and Fingers Spasticity in Poststroke Patients: A Prospective, Open-Label, Preliminary Clinical Trial. Evidence-BasedComplementaryandAlternativeMedicine2016:4648101, 2016

Physiopathology of muscular tonus; muscular hypertonia & hypotonia in rheumatism; treatment. El Dia Medico 30(79): 2211 Passim, 1958

Spinal cord stimulation for the treatment of muscle hypertonia in patients with chronic spinal cord injury. Applied Neurophysiology 48(1-6): 105, 1985

Patient with spinal muscular atrophy with respiratory distress type 1 presenting initially with hypertonia. Brain and Development 37(5): 542-545, 2015

Continuous intrathecal baclofen infusion by a programmable pump in 131 consecutive patients with severe spasticity of spinal origin. Neuromodulation 5(1): 16-24, 2002

Intrathecal baclofen therapy for spinal origin spasticity: spinal cord injury, spinal cord disease, and multiple sclerosis. Neuromodulation 2(2): 108-119, 1999